Antiproliferative activity of the bioactive compound from Silybum marianum in a human melanoma cell line with BRAF mutation: potential for therapeutic repurposing. Rev Fitos [Internet]. 2025 Jul. 9 [cited 2026 Jul. 30];19:e1812. Available from: https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1812